UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis

PloS one, 2015-06, Vol.10 (6), p.e0132119-e0132119

2015

Volltextzugriff (PDF)

Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers

PloS one, 2013-09, Vol.8 (9), p.e75184-e75184

2013

Volltextzugriff (PDF)

Serum microRNA-122 predicts survival in patients with liver cirrhosis

PloS one, 2012-09, Vol.7 (9), p.e45652-e45652

2012

Volltextzugriff (PDF)

Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition

Clinical cancer research, 2017-07, Vol.23 (14), p.3896-3905

2017

Volltextzugriff (PDF)

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study

PloS one, 2014-07, Vol.9 (7), p.e103532-e103532

2014

Volltextzugriff (PDF)

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

PloS one, 2011-10, Vol.6 (10), p.e26971-e26971

2011

Volltextzugriff (PDF)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis

PloS one, 2015-09, Vol.10 (9), p.e0138130-e0138130

2015

Volltextzugriff (PDF)

Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity

PloS one, 2012-02, Vol.7 (2), p.e30796-e30796

2012

Volltextzugriff (PDF)

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma

Translational oncology, 2013-06, Vol.6 (3), p.311-318

2013

Volltextzugriff (PDF)

Current and future treatment options for HCV

Annals of hepatology, 2009-04, Vol.8 (2), p.103-112

2009

Volltextzugriff (PDF)

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study

BMC medicine, 2012-09, Vol.10 (1), p.102-102, Article 102

2012

Volltextzugriff (PDF)

Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels

Neoplasia (New York, N.Y.), 2012-05, Vol.14 (5), p.410-IN10

2012

Volltextzugriff (PDF)

Mutagenic Effect of Ribavirin on Hepatitis C Nonstructural 5B Quasispecies In Vitro and During Antiviral Therapy

Gastroenterology (New York, N.Y. 1943), 2007-03, Vol.132 (3), p.921-930

2007

Volltextzugriff (PDF)

Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis

PloS one, 2013-08, Vol.8 (8), p.e71262

2013

Volltextzugriff (PDF)

Occludin a New HCV Entry Factor: Is the List of Essential Hepatitis C Virus Receptors Complete?

Gastroenterology (New York, N.Y. 1943), 2009-08, Vol.137 (2), p.727-728

2009

Volltextzugriff (PDF)

Tumor regression by combination antisense therapy against Plk1 and Bcl-2

Oncogene, 2003-01, Vol.22 (1), p.69-80

2003

Volltextzugriff (PDF)

Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells

The Journal of biological chemistry, 2002-11, Vol.277 (46), p.43623-43630

2002

Volltextzugriff (PDF)

High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis

European journal of cancer (1990), 2016-05, Vol.59, p.152-159

2016

Volltextzugriff (PDF)

Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis

Journal of hepatology, 2013-05, Vol.58 (5), p.956-961

2013

Volltextzugriff (PDF)

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3442-3449

2013

Volltextzugriff (PDF)

Novel Hepatitis C Drugs in Current Trials

Clinics in liver disease, 2008-08, Vol.12 (3), p.529-555

2008

Volltextzugriff (PDF)

Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization

Molecules (Basel, Switzerland), 2008-05, Vol.13 (5), p.1081-1110

2008

Volltextzugriff (PDF)

Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

The American journal of gastroenterology, 2011-09, Vol.106 (9), p.1663-1669

2011

Volltextzugriff (PDF)

Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients

Hepatology (Baltimore, Md.), 2013-10, Vol.58 (4), p.1270-1276

2013

Volltextzugriff (PDF)

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma

Journal of hepatology, 2013-10, Vol.59 (4), p.769-779

2013

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Humans
(71)
Life Sciences & Biomedicine
(65)
Male
(39)
Female
(38)
Gastroenterology & Hepatology
(35)
Middle Aged
(34)
Adult
(31)
Aged
(24)
Antiviral Agents - Therapeutic Use
(23)
Biological And Medical Sciences
(22)
Hepatitis C, Chronic - Drug Therapy
(21)
Medical Sciences
(19)
Infectious Diseases
(17)
Hepatitis C Virus
(16)
Human Viral Diseases
(15)
Interferon-Alpha - Therapeutic Use
(15)
Viral Diseases
(15)
Viral Hepatitis
(15)
Gastroenterology And Hepatology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis

Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers

Serum microRNA-122 predicts survival in patients with liver cirrhosis

Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis

Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma

Current and future treatment options for HCV

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study

Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels

Mutagenic Effect of Ribavirin on Hepatitis C Nonstructural 5B Quasispecies In Vitro and During Antiviral Therapy

Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis

Occludin a New HCV Entry Factor: Is the List of Essential Hepatitis C Virus Receptors Complete?

Tumor regression by combination antisense therapy against Plk1 and Bcl-2

Cyclic AMP Induces Transactivation of the Receptors for Epidermal Growth Factor and Nerve Growth Factor, Thereby Modulating Activation of MAP Kinase, Akt, and Neurite Outgrowth in PC12 Cells

High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis

Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

Novel Hepatitis C Drugs in Current Trials

Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization

Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma

Suchergebnisse filtern